DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025

Rhea-AI Summary

DaVita Inc. (NYSE: DVA) has announced its participation in the upcoming Barclays Global Healthcare Conference 2025. The company's CFO Joel Ackerman and Group VP of Investor Relations Nic Eliason will engage in a fireside chat with investors on March 11, 2025, at 9:00 a.m. EDT.

DaVita is a comprehensive kidney care provider with a 25-year track record in clinical quality and innovation. As of December 31, 2024, the company serves 281,100 patients across 3,166 outpatient dialysis centers, with 2,657 centers in the United States and 509 centers across 13 other countries. The company specializes in various aspects of kidney health, from disease progression management to transplantation support and home dialysis services.

News Market Reaction – DVA

+0.26%

1 alert

+0.26% News Effect

On the day this news was published, DVA gained 0.26%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

DENVER, March 6, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at the Barclays Global Healthcare Conference 2025 on Tuesday, March 11, 2025, at 9:00 a.m. EDT.

To view the live webcast, visit the Barclays page and create a free registration.

About DaVita Inc.

DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of December 31, 2024, DaVita served approximately 281,100 patients at 3,166 outpatient dialysis centers, of which 2,657 centers were located in the United States and 509 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

Contact Information
IR@davita.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-to-participate-in-the-barclays-global-healthcare-conference-2025-302394668.html

SOURCE DaVita

FAQ

When and where will DaVita (DVA) present at the Barclays Healthcare Conference 2025?

DaVita will present on Tuesday, March 11, 2025, at 9:00 a.m. EDT during a fireside chat at the Barclays Global Healthcare Conference 2025.

How many dialysis centers does DaVita (DVA) operate globally as of 2024?

As of December 31, 2024, DaVita operates 3,166 outpatient dialysis centers globally, with 2,657 in the United States and 509 across 13 other countries.

What is DaVita's (DVA) current patient count worldwide?

DaVita serves approximately 281,100 patients worldwide as of December 31, 2024.

Which DaVita (DVA) executives will participate in the Barclays conference?

CFO Joel Ackerman and Group Vice President of Investor Relations Nic Eliason will participate in the conference.

What services does DaVita (DVA) provide in kidney care?

DaVita provides comprehensive kidney care services including disease progression management, transplantation support, acute hospital care, and home dialysis services.